Natalie Shiff

Senior Medical Director Fate Therapeutics

Seminars

Wednesday 16th September 2026
Proving Durable Autoimmune Responses to Expand Safety, Access & Clinical Impact
9:25 am
  • Discussing CAR-T expansion into autoimmunity to enhance future developments
  • Showcasing autoimmune clinical data to demonstrate durable responses while improving patient safety and tolerability
  • Sharing evolving profiles to illustrate sustained persistence and strengthen confidence in non-conditioning approaches
Natalie Shiff - Fate Therapeutics - Expert Speaker at the 11th CAR-TCR Summit 2026